Literature DB >> 9731526

Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.

J Liu1, M Aoki, I Illa, C Wu, M Fardeau, C Angelini, C Serrano, J A Urtizberea, F Hentati, M B Hamida, S Bohlega, E J Culper, A A Amato, K Bossie, J Oeltjen, K Bejaoui, D McKenna-Yasek, B A Hosler, E Schurr, K Arahata, P J de Jong, R H Brown.   

Abstract

Miyoshi myopathy (MM) is an adult onset, recessive inherited distal muscular dystrophy that we have mapped to human chromosome 2p13. We recently constructed a 3-Mb P1-derived artificial chromosome (PAC) contig spanning the MM candidate region. This clarified the order of genetic markers across the MM locus, provided five new polymorphic markers within it and narrowed the locus to approximately 2 Mb. Five skeletal muscle expressed sequence tags (ESTs) map in this region. We report that one of these is located in a novel, full-length 6.9-kb muscle cDNA, and we designate the corresponding protein 'dysferlin'. We describe nine mutations in the dysferlin gene in nine families; five are predicted to prevent dysferlin expression. Identical mutations in the dysferlin gene can produce more than one myopathy phenotype (MM, limb girdle dystrophy, distal myopathy with anterior tibial onset).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731526     DOI: 10.1038/1682

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  270 in total

1.  A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy.

Authors:  C G Bönnemann; G F Cox; F Shapiro; J J Wu; C A Feener; T G Thompson; D C Anthony; D R Eyre; B T Darras; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy.

Authors:  Alberto Lerario; Filippo Cogiamanian; Chiara Marchesi; Marzia Belicchi; Nereo Bresolin; Laura Porretti; Yvan Torrente
Journal:  BMC Musculoskelet Disord       Date:  2010-07-11       Impact factor: 2.362

Review 4.  Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair.

Authors:  Angela Lek; Frances J Evesson; R Bryan Sutton; Kathryn N North; Sandra T Cooper
Journal:  Traffic       Date:  2011-09-06       Impact factor: 6.215

Review 5.  Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.

Authors:  Alisa D Blazek; Brian J Paleo; Noah Weisleder
Journal:  Physiology (Bethesda)       Date:  2015-11

Review 6.  Membrane Repair: Mechanisms and Pathophysiology.

Authors:  Sandra T Cooper; Paul L McNeil
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

7.  Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation.

Authors:  Anuradha Balasubramanian; Genri Kawahara; Vandana A Gupta; Anete Rozkalne; Ariane Beauvais; Louis M Kunkel; Emanuela Gussoni
Journal:  FASEB J       Date:  2014-03-31       Impact factor: 5.191

8.  Placental proteomics: a shortcut to biological insight.

Authors:  J M Robinson; D D Vandré; W E Ackerman
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

9.  Coupling of excitation to Ca2+ release is modulated by dysferlin.

Authors:  Valeriy Lukyanenko; Joaquin M Muriel; Robert J Bloch
Journal:  J Physiol       Date:  2017-06-26       Impact factor: 5.182

10.  Refined mapping of the Welander distal myopathy region on chromosome 2p13 positions the new candidate region telomeric of the DYSF locus.

Authors:  Désirée von Tell; Carl E G Bruder; Louise V B Anderson; Maria Anvret; Gabrielle Ahlberg
Journal:  Neurogenetics       Date:  2003-06-27       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.